(Q30306955)

16 June 2017

title

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis (English)

1 reference

16 June 2017

0 references

Caldwell SH

1

1 reference

16 June 2017

Hespenheide EE

2

1 reference

16 June 2017

Redick JA

3

1 reference

16 June 2017

Iezzoni JC

4

1 reference

16 June 2017

Battle EH

5

1 reference

16 June 2017

Sheppard BL

6

1 reference

16 June 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

The American Journal of Gastroenterology

16 June 2017

published in

1 reference

16 June 2017

volume

96

1 reference

16 June 2017

issue

2

1 reference

16 June 2017

page(s)

519-525

1 reference

Medical significance of peroxisome proliferator-activated receptors.

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

Thiazolidinediones: a new class of antidiabetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

Mitochondrial abnormalities in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

Guidelines for healthy weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

Biliary imaging: magnetic resonance cholangiography versus endoscopic retrograde cholangiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03553.X

10.1111/J.1572-0241.2001.03553.X

21 January 2018

Identifiers

DOI

1 reference

16 June 2017

1 reference